$100 Invested In This Stock 5 Years Ago Would Be Worth $600 Today

Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 31.7% on an annualized basis producing an average annual return of 44.98%. Currently, Viking Therapeutics has a m

BenzingaJun 18 15:00 ET

Here's Why Viking Therapeutics (VKTX) Stock Skyrocketed in Q1

Yahoo FinanceJun 18 08:34 ET

Institutional Investors in Viking Therapeutics, Inc. (NASDAQ:VKTX) Lost 7.7% Last Week but Have Reaped the Benefits of Longer-term Growth

Key Insights Institutions' substantial holdings in Viking Therapeutics implies that they have significant influence over the company's share price A total of 15 investors have a majority stake in th

Simply Wall StJun 18 08:26 ET

Express News | Truist Securities Maintains Buy on Viking Therapeutics, Maintains $120 Price Target

BenzingaJun 17 11:29 ET

Viking Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/17/2024 135.99% Truist Securities $120 → $120 Maintains Buy 06/04/2024 — Raymond James Reiterates → St

BenzingaJun 17 11:28 ET

Truist Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating

Truist Financial analyst Joon Lee maintains $Viking Therapeutics(VKTX.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 48.3% and a total average return of 23.0% ove

moomoo NewsJun 17 07:33 ET · Ratings